MD Anderson Cancer Center and Empyrean Medical Systems Inc. formed an exclusive license and joint development agreement to advance novel technologies and products in the fields of radiation oncology and cancer therapeutics.
MD Anderson Cancer Center and Erasca formed a strategic research and development collaboration to evaluate multiple agents from Erasca’s pipeline targeting the RAS/MAPK pathway as either single-agent or combination therapies.
The National Cancer Institute approved the following clinical research studies last month.
Don’t sack the director because your cancer center’s score and ranking by U.S. News & World Report have slipped.
In the latest phase of its plan to invest over $1 billion in Orange County, City of Hope has opened a multi-specialty outpatient cancer center in the county and hired 29 physicians to practice there.
The Parker Institute for Cancer Immunotherapy has awarded nearly $4.5 million to its Early Career Researcher class of nine graduate and postdoctoral researchers.
Cathy Eng was named director for strategic relations for the Vanderbilt-Ingram Cancer Center.
James L. Gulley was elected vice president of The Society for Immunotherapy of Cancer. Gulley is co-director of the Center for Immuno-Oncology, the director of the Medical Oncology Service, and deputy director of the Center for Cancer Research at NCI.
Nina Burbure was named assistant professor in the Department of Radiation Oncology at Fox Chase Center.
Vanessa B. Wookey was named assistant professor in the Gastrointestinal Cancer Program at Fox Chase Cancer Center.
